Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
MSAC was delisted on the 17th of February, 2023.
53 hedge funds and large institutions have $105M invested in Medicus Sciences Acquisition Corp. Class A Ordinary Share in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 5 closing their positions.
2% more capital invested
Capital invested by funds: $104M → $105M (+$1.77M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2% less funds holding
Funds holding: 54 → 53 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
27% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$4.93M |
| 2 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
+$3.94M |
| 3 |
MSU
Mizuho Securities USA
New York
|
+$2.59M |
| 4 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
+$548K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$208K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
-$4.9M |
| 2 |
CC
Centiva Capital
New York
|
-$2.62M |
| 3 |
LSC
Logan Stone Capital
Chicago,
Illinois
|
-$1.94M |
| 4 |
SMA
Sage Mountain Advisors
Atlanta,
Georgia
|
-$758K |
| 5 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$409K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
51
Tower Research Capital (TRC)
New York
| $13K | -$3.94K | -400 | -23% |
|
52
JP Morgan Chase
New York
| $1K | – | – | – |
|
53
Bank of Montreal
Toronto,
Ontario, Canada
| $339 | +$89.9K | +9,123 | +36% |
|
|
CAC
54
Cowen and Company
New York
| – | -$4.9M | -500,000 | Closed |
|
|
CC
55
Centiva Capital
New York
| – | -$2.62M | -267,595 | Closed |
|
|
LSC
56
Logan Stone Capital
Chicago,
Illinois
| – | -$1.94M | -197,941 | Closed |
|
|
PCM
57
Pinz Capital Management
New York
| – | -$320K | -32,706 | Closed |
|
|
LC
58
Littlejohn & Co
Greenwich,
Connecticut
| – | -$196K | -20,000 | Closed |
|
MSAC Hedge Fund Activity: Q3 2022 in Review
53 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) for Q3 2022, worth a combined $105M — up 1.7% from $104M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of MSAC and 4 opened new positions — a net loss of 1 holder — while 11 trimmed existing stakes and 8 added.
The largest buyer was Weiss Asset Management, opening a new position worth an estimated $4.93M. The largest seller was Cowen and Company, exiting entirely with an estimated $4.9M sold.
- 53 institutional investors held Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) as of Q3 2022, down from 54 in Q2 2022.
- Funds reported $105M of Medicus Sciences Acquisition Corp. Class A Ordinary Share stock for Q3 2022, up 1.7% quarter-over-quarter.
- 4 funds opened new Medicus Sciences Acquisition Corp. Class A Ordinary Share positions in Q3 2022 and 5 closed out, a net change of -1 holder.
- The largest Medicus Sciences Acquisition Corp. Class A Ordinary Share buyer in Q3 2022 was Weiss Asset Management, an estimated $4.93M added.
- The largest Medicus Sciences Acquisition Corp. Class A Ordinary Share seller in Q3 2022 was Cowen and Company, an estimated $4.9M sold.
Based on aggregated 13F filings for Q3 2022.